Centrophenoxine for Health & Longevity - Quick Reference Sheet

Centrophenoxine for Health & Longevity

Created on 09/28/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Centrophenoxine is an older brain medicine, also sold as a supplement, used for memory and hoped to slow brain aging. Human evidence is thin: few small, decades-old studies with mixed results; life-span and age-pigment findings come only from animals. Side effects are mostly mild: restlessness, poor sleep, headache. The evidence is too small and dated to confirm memory or longevity benefits in healthy adults. (Full Review)

Protocol

Common supplement protocol
250 mg, one to three times daily
250–750 mg/day; split doses are standard; single doses above 500 mg increase jitteriness
Time of day
Morning and early afternoon
Stimulant-like effects can delay sleep onset
Baseline biomarkers
Blood pressure below 130/80 mmHg
Plus normal liver enzymes and adequate dietary choline (425 mg/day women, 550 mg/day men) before starting
Time to effect
Memory
3–8 weeks
Trial assessment window; self-reported alertness may appear within days
Aerobic capacity and fasting glucose
12 months
One small, non-randomized study at 3 g/day
Brain aging or life span
Not observable
Any effect would not be observable on a personal time scale

Benefits

Contraindications
  • Pregnancy, breastfeeding or trying to conceive
  • Epilepsy or any unprovoked seizure (within the past 5 years)
  • Uncontrolled hypertension (resting blood pressure ≥160/100 mmHg)
  • Bipolar disorder or any past episode of mania or hypomania
  • Psychosis or marked agitation
  • Alkylating chemotherapy (cyclophosphamide, chlorambucil)
  • Children and adolescents (under 18 years)
  • In-competition anti-doping testing
  • Severe liver impairment (Child-Pugh Class C) or severe kidney impairment (eGFR below 30 mL/min/1.73 m²)
Key Interactions
  • Cholinesterase inhibitors (donepezil, rivastigmine, galantamine): Caution
  • Anticholinergic prescription drugs (oxybutynin, tolterodine, amitriptyline): Monitor
  • Stimulant medications (methylphenidate, amphetamine, modafinil): Caution
  • Anticonvulsants (valproate, levetiracetam, lamotrigine): Caution
  • Over-the-counter anticholinergics (diphenhydramine, doxylamine): Monitor
  • Over-the-counter stimulants (pseudoephedrine, caffeine tablets): Caution
  • Additive cholinergic supplements (alpha-GPC, citicoline, DMAE, huperzine A): Caution
  • Stimulant supplements (yohimbine, synephrine): Caution

Risk & Side Effects

  • High:
  • Medium:
  • Low: Overstimulation, insomnia, headache and dizziness; gastrointestinal discomfort; drowsiness, confusion and raised blood pressure; mood changes; serious cardiac events and seizure
  • Speculative: Birth defects; unfavorable brain gene expression

Monitoring

Marker Target Why
Blood pressure <120/80 mmHg Its choline-like component raised blood pressure
Resting heart rate 50–70 beats/min Detects stimulant or cholinergic effects
ALT 10–25 U/L Liver processes the compound
AST 10–25 U/L Liver safety
eGFR >90 mL/min/1.73 m² Kidneys clear one of its breakdown products
Fasting glucose 75–90 mg/dL One study reported lower fasting glucose
Homocysteine 5–8 µmol/L Reflects choline and methylation status
Cognitive test score No established target; track change from own baseline Objective check of benefit
Pregnancy test Negative Excludes pregnancy

Cadence: Baseline before starting; blood pressure weekly for the first 4 weeks, then monthly; repeat labs and cognitive testing at 8–12 weeks, then every 6 months for as long as use continues

Qualitative Assessment

  • Sleep onset time and sleep quality
  • Daytime mental alertness and focus
  • Recall of names, lists and recent events
  • Mood stability, irritability or unusual elation
  • Headache frequency, jitteriness and stomach comfort